Approval · Notice of Compliance 6992 · 2005
HYZAAR: Notice of Compliance 6992
Issued June 2, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6992
- Date
- June 2, 2005
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Angiotensin ii receptor antagonist, diuretic
Products in this notice
Medicinal ingredients
- LOSARTAN POTASSIUM 50 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- LOSARTAN POTASSIUM 100 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB